Data sourced from ClinicalTrials.gov (NIH registry) Updated weekly IRB-supervised studies only
Home/AZ/Surprise
Updated October 2026 from ClinicalTrials.gov

Paid Clinical Trials in Surprise, AZ

Studies commonly pay $75 to $4,500 per completed study

1,006 clinical trials are currently recruiting participants within 30 miles of Surprise. Listings below come straight from the official NIH registry, alongside the area's top-rated research centers with real Google reviews.

1,006studies recruiting
9+research centers nearby
7condition categories
Live from the NIH registry

Studies recruiting near Surprise right now

Top 25 of 1,006 recruiting studies, sorted by proximity — each links to its official registry page

A Study Testing the Combination of Dasatinib or Imatinib to Chemotherapy Treatment With Blinatumomab for Children, Adolescents, and Young Adults With Philadelphia Chromosome Positive (Ph+) or ABL-Class Philadelphia Chromosome-Like (Ph-Like) B-cell Acute Lymphoblastic Leukemia (B-ALL)

B Acute Lymphoblastic Leukemia Phase 2 Interventional 222 participants sought
Phoenix Childrens Hospital — Phoenix, Arizona (27.1 mi) · Sponsor: National Cancer Institute (NCI)
See eligibility & contact on ClinicalTrials.gov (NCT06124157)

A Study to Investigate the Safety and Efficacy of KQB365 as Monotherapy and in Combination in Participants With Advanced Solid Malignancies

KRAS G12C Mutation, KRAS G12S Mutation Phase 1 Interventional 140 participants sought
Mayo Clinic, Phoenix — Phoenix, Arizona (27.1 mi) · Sponsor: Kumquat Biosciences Inc.
See eligibility & contact on ClinicalTrials.gov (NCT06720987)

A Study Evaluating the Efficacy and Safety of Inavolisib Plus CDK4/6 Inhibitor and Letrozole vs Placebo + CDK4/6i and Letrozole in Participants With Endocrine-Sensitive PIK3CA-Mutated, Hormone Receptor-Positive, HER2-Negative Advanced Breast Cancer

Breast Cancer Phase 3 Interventional 450 participants sought
City of Hope - Phoenix — Goodyear, Arizona (17.8 mi) · Sponsor: Hoffmann-La Roche
See eligibility & contact on ClinicalTrials.gov (NCT06790693)

A Clinical Study of Zilovertamab Vedotin (MK-2140) Plus Rituximab Plus Cyclophosphamide, Doxorubicin, and Prednisone (R-CHP) Versus Polatuzumab Vedotin Plus R-CHP in People With Diffuse Large B-cell Lymphoma (DLBCL) (MK-2140-011/waveLINE-011)

Lymphoma, Large B-Cell, Diffuse Phase 2 Interventional 594 participants sought
City of Hope - Phoenix ( Site 0202) — Goodyear, Arizona (17.8 mi) · Sponsor: Merck Sharp & Dohme LLC
See eligibility & contact on ClinicalTrials.gov (NCT06890884)

WISPer: Evaluation of MTX-463 in Participants With Idiopathic Pulmonary Fibrosis (IPF)

Idiopathic Pulmonary Fibrosis Phase 2 Interventional 164 participants sought
WISPer site in Phoenix, AZ — Phoenix, Arizona (27.1 mi) · Sponsor: Mediar Therapeutics
See eligibility & contact on ClinicalTrials.gov (NCT06967805)

A Protocol of Icotrokinra Therapy in Adult and Adolescent Participants With Moderately to Severely Active Ulcerative Colitis

Colitis, Ulcerative Phase 3 Interventional 882 participants sought
Research Solutions of Arizona — Litchfield Park, Arizona (14.1 mi) · Sponsor: Janssen Research & Development, LLC
See eligibility & contact on ClinicalTrials.gov (NCT07196748)

Pharmacokinetics, Safety, and Efficacy of Povorcitinib in Adolescent Participants With Moderate to Severe Hidradenitis Suppurativa

Hidradenitis Suppurativa (HS) Phase 2 Interventional 40 participants sought
Medical Dermatology Specialists Phoenix — Phoenix, Arizona (27.1 mi) · Sponsor: Incyte Corporation
See eligibility & contact on ClinicalTrials.gov (NCT07213973)

Study of TX000045 in Participants With Pulmonary Hypertension Due to Interstitial Lung Disease

Hypertension, Pulmonary, Lung Diseases, Interstitial Phase 2 Interventional 25 participants sought
Phoenix — Phoenix, Arizona (27.1 mi) · Sponsor: Tectonic Operating Company, Inc.
See eligibility & contact on ClinicalTrials.gov (NCT07473700)

RENAISSANCE 2: SPN-817 Phase 2, Double-Blind, Placebo-Controlled Study in Adults With Focal Onset Seizures

Focal Onset Seizures Phase 2 Interventional 216 participants sought
Xenoscience — Phoenix, Arizona (27.1 mi) · Sponsor: Supernus Pharmaceuticals, Inc.
See eligibility & contact on ClinicalTrials.gov (NCT06798896)

A Study of Buntanetap in Participants With PD

Parkinson's Disease (PD), Deep Brain Stimulation Phase 2, Phase 3 Interventional 500 participants sought
Banner Sun Health Research Institute - Cleo Roberts Center for Clinical Research — Sun City, Arizona (11.9 mi) · Sponsor: Annovis Bio Inc.
See eligibility & contact on ClinicalTrials.gov (NCT07284784)

A Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Anti-tumor Activity of CBI-1214 T Cell Engager in Participants With Advanced or Metastatic MSS/MSI-L Colorectal Cancer

Colorectal Cancer, Colorectal Cancer (CRC) Phase 1 Interventional 80 participants sought
Mayo Clinic Arizona — Phoenix, Arizona (27.1 mi) · Sponsor: Cartography Biosciences
See eligibility & contact on ClinicalTrials.gov (NCT07321106)

Transcatheter Tricuspid Valve Replacement With the Medtronic Intrepid™ Transcatheter Tricuspid Valve Replacement (TTVR) System in Severe Tricuspid Regurgitation

Severe Tricuspid Regurgitation N/A Interventional 1,186 participants sought
Abrazo Arizona Heart Hospital — Phoenix, Arizona (27.1 mi) · Sponsor: Medtronic Cardiovascular
See eligibility & contact on ClinicalTrials.gov (NCT07321899)

Lung-MAP: A Master Screening Protocol for Previously-Treated Non-Small Cell Lung Cancer

Previously Treated Non-Small Cell Lung Cancer Phase 2, Phase 3 Interventional 10,000 participants sought
CTCA at Western Regional Medical Center — Goodyear, Arizona (17.8 mi) · Sponsor: SWOG Cancer Research Network
See eligibility & contact on ClinicalTrials.gov (NCT03851445)

American Indian Chronic Renal Insufficiency Cohort Study (AI-CRIC Study)

Diabetes Mellitus, Chronic Kidney Diseases N/A Observational 500 participants sought
NIDDK-Phoenix Epidemiology and Clinical Research — Phoenix, Arizona (27.1 mi) · Sponsor: University of New Mexico
See eligibility & contact on ClinicalTrials.gov (NCT04185844)

A Study to Assess Disease Activity and Adverse Events of Intravenous (IV) Telisotuzumab Vedotin Compared to IV Docetaxel in Adult Participants With Previously Treated Non-Squamous Non-Small Cell Lung Cancer (NSCLC)

Non Small Cell Lung Cancer, c-MET Phase 3 Interventional 768 participants sought
Mayo Clinic Arizona /ID# 255858 — Phoenix, Arizona (27.1 mi) · Sponsor: AbbVie
See eligibility & contact on ClinicalTrials.gov (NCT04928846)

A Clinical Study of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) in People With Breast Cancer (MK-2870-032)

Breast Neoplasms, Triple Negative Breast Neoplasms Phase 3 Interventional 2,400 participants sought
Mayo Clinic Cancer Center ( Site 0034) — Phoenix, Arizona (27.1 mi) · Sponsor: Merck Sharp & Dohme LLC
See eligibility & contact on ClinicalTrials.gov (NCT06966700)

This Study Will Explore Whether a Combination of the Investigational Drug Mevrometostat (PF-06821497) and Enzalutamide Will Work Better Than Taking Enzalutamide Alone in Participants With mCSPC Who Are ARPI naïve.

Metastatic Castration Sensitive Prostate Cancer (mCSPC), Hormone Sensitive Prostate Cancer Phase 3 Interventional 1,000 participants sought
Ironwood Physicians P.C. dba Ironwood Cancer and Research Centers — Goodyear, Arizona (17.8 mi) · Sponsor: Pfizer
See eligibility & contact on ClinicalTrials.gov (NCT07028853)

Study to Evaluate the Maximal Use of Ruxolitinib Cream in Adult and Adolescent Participants With Hidradenitis Suppurativa

Hidradenitis Suppurativa Phase 1 Interventional 24 participants sought
Saguaro Dermatology — Phoenix, Arizona (27.1 mi) · Sponsor: Incyte Corporation
See eligibility & contact on ClinicalTrials.gov (NCT07049575)

A Study to Assess How Effective and Safe NVD003 is for Treating Patients With Congenital Pseudarthrosis of the Tibia.

Congenital Pseudarthrosis of Tibia Phase 3 Interventional 12 participants sought
Phoenix Children's Hospital, Inc. — Phoenix, Arizona (27.1 mi) · Sponsor: Novadip Biosciences
See eligibility & contact on ClinicalTrials.gov (NCT07112443)

Study of Revumenib in Combination With Intensive Chemotherapy in Newly Diagnosed Acute Myeloid Leukemia (AML) With a NPM1 Mutation

Acute Myeloid Leukemias Phase 3 Interventional 468 participants sought
Clinical Trial Site — Goodyear, Arizona (17.8 mi) · Sponsor: Syndax Pharmaceuticals
See eligibility & contact on ClinicalTrials.gov (NCT07211958)
Actively enrolling

Studies you may be able to join near Surprise

These studies are recruiting through partner research networks. We may be paid a referral fee if you complete their screening form — this never changes what you pay (nothing) or the compensation the study offers you.

See which clinical studies you may qualify for

A partner research network matches volunteers with studies that are currently enrolling in the United States. You answer a few screening questions about your health and where you live; if a study looks like a fit, its team contacts you to confirm eligibility.

Screening is free and takes a few minutes. Eligibility and any compensation are confirmed by the study team, not by this site.

Check your eligibility
Google-rated

Top-rated research centers in Surprise

Dedicated clinical research sites near you — with their real Google ratings, reviews and contact details

Clinical Research Institute of Arizona

★ 5.0
14506 W Granite Valley Dr Unit 121, Sun City West, AZ 85375
(623) 223-1580
"Lovely experience love all, the friendly kind staff 💛"
— Janet Guzzardo, 5★

Arizona Clinical Trials

15396 N 83rd Ave Ste A303, Peoria, AZ 85382
(480) 360-4000

Sun City Clinical Research

★ 4.7
11851 N 51st Ave Bldg G, Glendale, AZ 85304
(623) 253-9777
"Friendly caring staff made the process simple and easy. Would recommend them for other clinical studies."
— Mark Burns, 5★

Arizona Research Center

★ 4.7
15601 N 28th Ave, Phoenix, AZ 85053
(602) 863-6363
"Friendly staff, efficient, and good at what they do."
— Caleb Willow, 5★

Clinical Research Institute

3090 N Litchfield Rd, Goodyear, AZ 85395
(623) 223-1580

Onyx Clinical Research

★ 4.7
14100 N 83rd Ave Ste 260 Suite 260, Peoria, AZ 85381
(602) 830-3794
"I was a patient in a clinical trial by Onyx back in January of this year. Communication was always sparse, which was not a huge deal at the time, how…"
— Brent Simmons, 1★

Epic Medical Research

★ 4.6
14810 N Del Webb Blvd, Sun City, AZ 85351
(623) 223-5725
"My experience at epic medical research has been wonderful. The staff is very friendly and helpful. I really enjoy Akshaya -CRC she is always so he…"
— Anthony Castro, 5★

Hope Research Institute - Phoenix

★ 5.0
4550 E Bell Rd Bldg 6 Suite 158, Phoenix, AZ 85032
(602) 288-4673
"I have gone to Hope Research Institute for health-related studies.<br>It is close to the 101 and Warner Rd, so it is easy to get to anywhere in the C…"
— Al C, 5★

Scottsdale Clinical Trials

★ 4.7
8997 E Desert Cove Ave Fl 2, Scottsdale, AZ 85260
(480) 382-7909
"I'm on a study for psoriasis and am seeing big improvement"
— Sonia Powers, 5★

Clinical trials in Surprise: what's recruiting

The Surprise area currently has 1,006 studies open to new participants, according to the ClinicalTrials.gov registry maintained by the U.S. National Institutes of Health. Among the studies closest to Surprise, the most active research areas are:

  • Cancer & Oncology11 studies
  • Liver & Kidney2 studies
  • Lungs & Breathing2 studies
  • Heart & Vascular2 studies
  • Brain & Mental Health2 studies

Every listing shows the study phase, the recruiting site and its distance from Surprise, and links to the official registry page where eligibility criteria and study contacts are published. Compensation is set by each sponsor: industry surveys report typical payments of $75 to $4,500 per completed study, with short observational studies at the low end and multi-visit or overnight Phase 1 studies at the high end.

How to enroll in a paid study in Surprise

Start with a study whose condition matches your profile — or a healthy-volunteer study if you have no diagnosis. Contact the research site through the registry page, complete a short phone screen, then attend an in-person screening visit. If you qualify, the study team walks you through the informed consent document, which details every procedure, risk and payment before you commit. You can withdraw at any point, and enrollment is always free.

Surprise participants can also register with the dedicated research centers listed above — many maintain volunteer databases and call when a matching study opens — or sign up for our email alert below to hear when a new study starts recruiting within 30 miles of your ZIP code.

Frequently asked questions

Are clinical trials in Surprise safe?
Every trial on this page is registered on ClinicalTrials.gov, the official NIH registry, and is overseen by an Institutional Review Board (IRB). Before joining you receive an informed consent document detailing procedures, risks and compensation. Participation is voluntary and you can withdraw at any time.
How do I join a study in Surprise, AZ?
Pick a study that matches your profile, contact the research site (or apply through the study links on this page), pass a phone pre-screen, then attend an in-person screening visit. If you qualify, you review and sign the informed consent and the study begins. The process typically takes 1-3 weeks.
What is the difference between a research center and a hospital study in Surprise?
Dedicated research centers (listed on this page with their Google ratings) run studies as their core business — often healthy-volunteer and vaccine studies with structured compensation. Hospital and university studies tend to focus on patients with specific conditions. Both types are registered and IRB-supervised.
How often do new paid studies open in Surprise?
Constantly — trials open and close enrollment every week. This page is refreshed weekly from the NIH registry. Join the email alert to be notified when a new study opens within 30 miles of Surprise.
Can I be in more than one clinical trial at a time?
Generally no — most studies exclude participants currently enrolled in another trial, and paid Phase 1 studies enforce a washout period (often 30 days or more) between studies. Frequent healthy volunteers in Surprise typically complete one or two studies per year.

Paid clinical trials near Surprise

Other metros within reach

Peoria, AZ1,279 Glendale, AZ1,447 Phoenix, AZ1,447 Scottsdale, AZ1,410 Tempe, AZ1,448 Chandler, AZ1,385 Mesa, AZ1,383 Gilbert, AZ1,385

By condition

Eligibility and exclusions, condition by condition

Alcoholic Liver Disease in Surprise Chronic Kidney Disease (HealthMatch) in Surprise Bladder Issues Due To Spinal Cord Injury in Surprise All conditions

More of AZ

Tempe1,448 Phoenix1,447 Glendale1,447 Scottsdale1,410 Gilbert1,385 Chandler1,385 Mesa1,383 Peoria1,279 Tucson470 Yuma9

New paid studies open every week

Get an email when a new clinical trial starts recruiting within 30 miles of your ZIP code. No spam — only real studies from the NIH registry.

By subscribing you agree to receive study alert emails. Unsubscribe anytime in one click.

Get free trial alerts